← All Maravai Lifesciences Holdings, INC filings

Maravai Lifesciences Holdings, INC Form 4 insider transactions

NASDAQ
MRVI
Maravai Lifesciences Holdings, INC
Form 4: Maravai LifeSciences Executive Andrew Burch Reports Stock Disposal for Tax Obligations
Andrew Burch, President of Nucleic Acid Production at Maravai LifeSciences, disposed of 16,758 shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
MRVI
Maravai Lifesciences Holdings, INC
Form 4: Maravai LifeSciences Executive Buzzeo Reports Tax-Related Stock Disposal
Rebecca Buzzeo, Chief Commercial Officer of Maravai LifeSciences, reports disposing of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
MRVI
Maravai Lifesciences Holdings, INC
Form 4: Maravai LifeSciences Holdings General Counsel Kurt Oreshack Reports Stock Transaction
Kurt Oreshack, General Counsel of Maravai LifeSciences Holdings, reports the disposal of 4,551 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.
NASDAQ
MRVI
Maravai Lifesciences Holdings, INC
Form 4: Maravai LifeSciences Executive Christine Dolan Reports Stock Transaction
Christine Dolan, an executive at Maravai LifeSciences, reported the disposal of 5,383 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.
NASDAQ
MRVI
Maravai Lifesciences Holdings, INC
Form 4: Maravai LifeSciences Executive Peter Leddy Reports Stock Transaction
Peter Leddy, Chief Administrative Officer of Maravai LifeSciences, reports disposition of shares to cover tax obligations.
NASDAQ
MRVI
Maravai Lifesciences Holdings, INC
Form 4: Maravai LifeSciences CFO Kevin Herde Reports Stock Transaction
Kevin Herde, CFO of Maravai LifeSciences Holdings, Inc., reports the disposal of 8,624 shares of Class A Common Stock to cover tax obligations.
NASDAQ
MRVI
Maravai Lifesciences Holdings, INC
Form 4: Maravai LifeSciences Holdings Director Carl Hull Reports Changes in Beneficial Ownership
Carl Hull, a director and Executive Chairman of Maravai LifeSciences Holdings, reported changes in beneficial ownership of Class A Common Stock due to tax withholding obligations and holdings through Glossatori, LLC.